OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook

Investing.com -- RBC Capital Markets has downgraded OptimizeRx Corp (NASDAQ:OPRX ) to "sector perform," reflecting a tempered outlook on the company's growth prospects. 

RBC analysts cited challenges in the company's direct-to-consumer segment, particularly as clients transition to a self-service model that generates lower revenue but offers higher margins. 

This shift, coupled with weaker bookings attributed to the timing of the Medicx acquisition in late 2023, is expected to dampen revenue growth through the first half of 2025.

OptimizeRx's updated revenue projections for 2025 have been revised downward to $94 million, reflecting a modest 2.7% growth compared to an earlier forecast of 11%. 

This adjustment aligns with RBC's recalibrated EBITDA estimate, now at $10.4 million for 2025, reflecting subdued growth expectations. Consequently, RBC has also lowered its price target for the stock to $6 from $7.

The company's challenges in the DTC business are partly offset by growth in its healthcare provider-focused offerings. 

OptimizeRx has seen progress in this segment, signing 22 Digital Advertising and Activation Platform deals in 2024, up from 24 deals in all of 2023. 

However, this growth has not been sufficient to overcome the revenue shortfalls in the DTC segment.

As long as the legacy provider business does not show a more strong growth trajectory, RBC analysts expect the stock to remain range-bound. 

In addition, investors are concerned about the recent leadership changes, including the resignation of CEO Will Febbo.

Shares of the digital health technology company were down 2.8% in pre-open trade at 08:27 ET (13:27 GMT).

Source: Investing.com

Последние публикации
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.